A network of 13 African countries has joined forces with global researchers to launch the largest clinical trial of potential Covid-19 treatments on the continent. The Anticov study, involving Antwerp’s Institute of Tropical Medicine and international research institutions, aims to identify treatments that can be used to treat mild and moderate cases of Covid-19 early and prevent spikes in hospitalisation that could overwhelm fragile and already overburdened health systems in Africa. The clinical trial will be carried out at 19 sites in 13 countries and led by doctors from African countries. The initiative emerged after calls for responses to the coronavirus better tailored to the developing world and the challenges of often underfunded healthcare systems. The study will test the efficacy of treatments in 2,000 to 3,000 mild-to-moderate patients in Burkina Faso, Cameroon, Ivory Coast, the Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Ghana, Guinea, Kenya, Mali, Mozambique, Sudan, and Uganda, with the aim of identifying treatments that can prevent progression of coronavirus to severe disease and also limit transmission.
SOURCE: THE GUARDIAN
More Stories
Botswana and Cape Verde Moved to Level 3- High Risk
10 Best Experiences in Kenya
South Africa Relaxes Travel Restrictions
These Upscale Resorts are Ideal for Anyone Craving Time in Nature
Astronomical Tourism has Become Famous in Egypt
Raising Awareness on Environmental Issues in Zimbabwe through Creativity
Fast Track to a Modern Senegal
The Cape Verde Rapper with a Feminist Message
French Gallerist Cecile Fakhoury on The Contemporary African Art Scene
8 Queer-Owned African Fashion Brands to Check Out For Pride
Tunisian City Attracts a New Type of Tourist
DYK that the Green Point Lighthouse is the Oldest Operational Lighthouse in South Africa?